Stock Events

Stock Events

Metagenomi Therapeutics (MGX) Q2 2025 Earnings

13MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.78

-0.61

-0.45

-0.29

Details

Expected EPS

-0.608519

Actual EPS

-0.68

Surprise EPS

-0.07

Surprise Percent

+11.75%

Description

Metagenomi Therapeutics (MGX) has reported earnings of -0.68 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.